The research is studying virtual reality (VR)-directed brain-gut behavioral therapy (BGBT) as a pain treatment option for hospitalized patients with inflammatory bowel disease (IBD). This study is being done to learn if VR-directed BGBT is feasible and acceptable for patients with IBD in addressing pain in the hospital setting.
The study hypothesizes that:
* At least 75% of enrolled participants will complete the VR-directed BGBT inpatient program * Hospitalized patients with IBD will find VR-directed BGBT acceptable as a pain treatment option in the inpatient setting.
Patients with Inflammatory Bowel Disease and self-reported pain
Hospitalized for management of IBD (inpatient medicine services at Michigan Medicine)
Patients that do not report pain
Anticipated length of hospital stay is less than 72 hours
Patients that have previously had a seizure, loss of awareness, or other symptoms linked to an epileptic condition
Patients with binocular vision loss